PLK1 and neoplasm: These experimental results demonstrate that siPlk1s can be delivered to target cells in the tumor tissues by the as-developed core/shell nano-vehicle with active tumor-targeting capability and knockdown PLK1 protein, inhibit cell proliferation, induce cell apoptosis, and eventually suppress tumor progression.